The Effects of Musical Expertise on Sensory Processing

The goal of this thesis was to assess sensorimotor musical experience and its impact on the way that individuals perceive and interact with real-world musical stimuli. Experiment #1 investigated multisensory integration in 14 musicians and 10 non-musicians using a two alternative forced-choice (2AFC) discrimination task, and was designed to examine whether musical expertise augmented multisensory enhancement. Musical experience did not alter the outcomes of multisensory integration, but there may be asymmetries between musicians and non-musicians in their use of auditory cues. Experiment #2 was a neuroimaging case study investigating the influence of musical familiarity on the kinesthetic motor imagery of dance accompanied by music in expert dancers. Familiarity resulted in increased hemodynamic responses in the supplementary motor area (SMA) and decreased responses in Heschls gyrus (HG). These findings provide new evidence regarding the influence of musical expertise on sensory processing using real-world complex stimuli. This thesis suggests that expert practice shapes the way experts perceive and interact with their environments, and emphasizes the need for, and challenges of using naturalistic stimuli

Leveraging environmental research and observation networks to advance soil carbon science

Soil organic matter (SOM) is a critical ecosystem variable regulated by interacting physical, chemical and biological processes. Collaborative efforts to integrate perspectives, data, and models from interdisciplinary research and observation networks can significantly advance predictive understanding of SOM. We outline how integrating three networks – the Long‐Term Ecological Research, with a focus on ecological dynamics, the Critical Zone Observatories with strengths in landscape/geologic context, and the National Ecological Observatory Network with standardized multi‐scale measurements—can advance SOM knowledge. This integration requires improved data dissemination and sharing, coordinated data collection activities, and enhanced collaboration between empiricists and modelers within and across networks

Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease

We integrated lipidomics and genomics to unravel the genetic architecture of lipid metabolism and identify genetic variants associated with lipid species putatively in the mechanistic pathway for coronary artery disease (CAD). We quantified 596 lipid species in serum from 4,492 individuals from the Busselton Health Study. The discovery GWAS identified 3,361 independent lipid-loci associations, involving 667 genomic regions (479 previously unreported), with validation in two independent cohorts. A meta-analysis revealed an additional 70 independent genomic regions associated with lipid species. We identified 134 lipid endophenotypes for CAD associated with 186 genomic loci. Associations between independent lipid-loci with coronary atherosclerosis were assessed in ∼ 456,000 individuals from the UK Biobank. Of the 53 lipid-loci that showed evidence of association (P \u3c 1 × 10−3), 43 loci were associated with at least one lipid endophenotype. These findings illustrate the value of integrative biology to investigate the aetiology of atherosclerosis and CAD, with implications for other complex diseases

Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT

Background In REDUCE‐IT (Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial), icosapent ethyl (IPE) versus placebo) reduced cardiovascular death, myocardial infarction, stroke, coronary revascularization, or unstable angina requiring hospitalization, but was associated with increased atrial fibrillation/atrial flutter (AF) hospitalization (3.1% IPE versus 2.1% placebo; P=0.004). Methods and Results We performed post hoc efficacy and safety analyses of patients with or without prior AF (before randomization) and with or without in‐study time‐varying AF hospitalization to assess relationships of IPE (versus placebo) and outcomes. In‐study AF hospitalization event rates were higher in patients with prior AF (12.5% versus 6.3%, IPE versus placebo; P=0.007) versus without prior AF (2.2% versus 1.6%, IPE versus placebo; P=0.09). Serious bleeding rates trended higher in patients with (7.3% versus 6.0%, IPE versus placebo; P=0.59) versus without prior AF (2.3% versus 1.7%, IPE versus placebo; P=0.08). With IPE, serious bleeding trended higher regardless of prior AF (interaction P value [Pint]=0.61) or postrandomization AF hospitalization (Pint=0.66). Patients with prior AF (n=751, 9.2%) versus without prior AF (n=7428, 90.8%) had similar relative risk reductions of the primary composite and key secondary composite end points with IPE versus placebo (Pint=0.37 and Pint=0.55, respectively). Conclusions In REDUCE‐IT, in‐study AF hospitalization rates were higher in patients with prior AF especially in those randomized to IPE. Although serious bleeding trended higher in those randomized to IPE versus placebo over the course of the study, serious bleeding was not different regardless of prior AF or in‐study AF hospitalization. Patients with prior AF or in‐study AF hospitalization had consistent relative risk reductions across primary, key secondary, and stroke end points with IPE. Registration URL: https://clinicaltrials.gov/ct2/show/NCT01492361; Unique Identifier: NCT0149236